wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q28474747-619AFBCD-73E1-4F56-A570-29313C1239F1
Q28474747-619AFBCD-73E1-4F56-A570-29313C1239F1
BestRank
Statement
http://www.wikidata.org/entity/statement/Q28474747-619AFBCD-73E1-4F56-A570-29313C1239F1
The integrin antagonist cilengitide activates alphaVbeta3, disrupts VE-cadherin localization at cell junctions and enhances permeability in endothelial cells
P2860
Q28474747-619AFBCD-73E1-4F56-A570-29313C1239F1
BestRank
Statement
http://www.wikidata.org/entity/statement/Q28474747-619AFBCD-73E1-4F56-A570-29313C1239F1
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
3d2e28c820e00d0cd92846d9d375b99cf62f7956
P2860
A randomized multi-center phase II trial of the angiogenesis inhibitor Cilengitide (EMD 121974) and gemcitabine compared with gemcitabine alone in advanced unresectable pancreatic cancer.